Literature DB >> 6743522

Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen.

T L Svendsen, K Viskum, N Hansborg, S M Thorpe, N C Nielsen.   

Abstract

A 28-year-old woman with lymphangioleiomyomatosis had severe changes in the chest radiograph and recurrent pneumothoraces. Pathological tissue from the lung was progesterone receptor positive. After treatment with medroxyprogesterone her condition improved, but did not become clinically stable until after bilateral oophorectomy. Even after oophorectomy her condition deteriorated, when the dose of medroxyprogesterone was decreased. For one year after oophorectomy she has had no episodes of pneumothorax or breathlessness. In order to depress oestrogen activity further the anti-oestrogen drug tamoxifen was added to her usual treatment with medroxyprogesterone. During 2 weeks of treatment with tamoxifen and medroxyprogesterone marked increase of the changes in the chest radiograph were seen and a pneumothorax occurred. After discontinuation of tamoxifen the condition improved and has since been stable on medroxyprogesterone treatment.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6743522

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  8 in total

Review 1.  Minireview: Lymphangioleiomyomatosis (LAM): The "Other" Steroid-Sensitive Cancer.

Authors:  Hen Prizant; Stephen R Hammes
Journal:  Endocrinology       Date:  2016-07-13       Impact factor: 4.736

2.  Pulmonary tuberous sclerosis treated with tamoxifen and progesterone.

Authors:  C J Westermann; A C Oostveen; S S Wagenaar; C Hilvering; S E Overbeek; D Verheijen-Breemhaar; B Corrin
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

3.  Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

Authors:  Francis X McCormack; Nishant Gupta; Geraldine R Finlay; Lisa R Young; Angelo M Taveira-DaSilva; Connie G Glasgow; Wendy K Steagall; Simon R Johnson; Steven A Sahn; Jay H Ryu; Charlie Strange; Kuniaki Seyama; Eugene J Sullivan; Robert M Kotloff; Gregory P Downey; Jeffrey T Chapman; MeiLan K Han; Jeanine M D'Armiento; Yoshikazu Inoue; Elizabeth P Henske; John J Bissler; Thomas V Colby; Brent W Kinder; Kathryn A Wikenheiser-Brokamp; Kevin K Brown; Jean F Cordier; Cristopher Meyer; Vincent Cottin; Jan L Brozek; Karen Smith; Kevin C Wilson; Joel Moss
Journal:  Am J Respir Crit Care Med       Date:  2016-09-15       Impact factor: 21.405

Review 4.  Chronic obstructive pulmonary disease: less common causes--an algorithm for the primary care physician.

Authors:  R C St John; J E Gadek; E R Pacht
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

5.  Relation of pulmonary lymphangio-leiomyomatosis to use of the oral contraceptive pill and fertility in the UK: a national case control study.

Authors:  I Wahedna; S Cooper; J Williams; I C Paterson; J R Britton; A E Tattersfield
Journal:  Thorax       Date:  1994-09       Impact factor: 9.139

6.  Primary abdominal lymphangioleiomyomatosis: report of a case.

Authors:  Yuan Ding; Sheng Yan; Yang Tian; Zhiwei Li; Jun Pan; Qiyi Zhang; Yan Wang; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2015-03-05       Impact factor: 2.754

7.  Benign Metastasizing Leiomyomatosis to the Skin and Lungs, Intravenous Leiomyomatosis, and Leiomyomatosis Peritonealis Disseminata: A Series of Five Cases.

Authors:  João Boavida Ferreira; Rafael Cabrera; Filipa Santos; Andreia Relva; Hugo Vasques; António Gomes; António Guimarães; António Moreira
Journal:  Oncologist       Date:  2022-02-03

8.  Association of retroperitoneal lymphangioleiomyomatosis with endosalpingiosis: a case report.

Authors:  José Manuel Lorente Herce; Virgilio Ruiz Luque; José Aguilar Luque; Pablo Martínez García; Daniel Díaz Gómez
Journal:  Cases J       Date:  2009-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.